Allosteric Bioscience, Inc. — Form D

Allosteric Bioscience, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-15. The offering totals $3.0M, of which $920K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-12-15
• Form: D
• Accession: 0001477932-21-009274
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $920K
• Remaining: $2.1M
• Minimum investment: $5K
• Investors: 14
• Date of first sale: 2021-12-08
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-425080

Issuer

• Name: Allosteric Bioscience, Inc.
• CIK: 0001873155
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 315 East 86th Street - 17GE, New York, NY, 10028
• Phone: 646-391-7957

Officers, directors & promoters (3)

More

• CIK 1873155 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search